These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26251601)

  • 21. Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates.
    Hernandez G; Mahmoudi S; Cyr M; Diaz J; Blanchet PJ; Lévesque D
    Mov Disord; 2019 May; 34(5):717-726. PubMed ID: 30675935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review.
    Yin J; Barr AM; Ramos-Miguel A; Procyshyn RM
    Curr Neuropharmacol; 2017; 15(1):174-183. PubMed ID: 27264948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent effects of dopamine receptor inactivation on cocaine-induced behaviors in male rats: Evidence of dorsal striatal D2 receptor supersensitivity.
    Crawford CA; Teran A; Ramirez GI; Katz CG; Mohd-Yusof A; Eaton SE; Real V; McDougall SA
    J Neurosci Res; 2019 Dec; 97(12):1546-1558. PubMed ID: 31304635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report.
    Tadokoro S; Nonomura N; Kanahara N; Hashimoto K; Iyo M
    Clin Psychopharmacol Neurosci; 2017 Feb; 15(1):79-81. PubMed ID: 28138118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case series on aripiprazole and dopamine supersensitivity psychosis.
    Russell G; Reinfeld S; Kam O; Lee G; Weiss M; Koola MM
    Int Clin Psychopharmacol; 2022 May; 37(3):122-128. PubMed ID: 35143441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis.
    Tachibana M; Niitsu T; Watanabe M; Hashimoto T; Kanahara N; Ishikawa M; Iyo M
    Asian J Psychiatr; 2016 Dec; 24():28-32. PubMed ID: 27931902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
    Fallon P; Dursun SM
    J Psychopharmacol; 2011 Jun; 25(6):755-62. PubMed ID: 20147573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
    Hurlé MA
    J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unifying theory for the pathoetiologic mechanism of tardive dyskinesia.
    Ali Z; Roque A; El-Mallakh RS
    Med Hypotheses; 2020 Mar; 140():109682. PubMed ID: 32200182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.
    Lockwood JT; Remington G
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):407-21. PubMed ID: 26166007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes.
    Grotegut CA; Ngan E; Garrett ME; Miranda ML; Ashley-Koch AE; Swamy GK
    Am J Obstet Gynecol; 2017 Sep; 217(3):367.e1-367.e9. PubMed ID: 28526450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia.
    Levchenko A; Vyalova N; Pozhidaev IV; Boiko AS; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM; Ivanova SA
    Hum Psychopharmacol; 2019 Jan; 34(1):e2685. PubMed ID: 30623492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of risperidone by CYP2D6 and the presence of drug-induced dopamine supersensitivity psychosis in patients with schizophrenia.
    Kanahara N; Yoshimura K; Nakamura M; Oda Y; Watanabe M; Iyo M
    Int Clin Psychopharmacol; 2019 May; 34(3):124-130. PubMed ID: 30870237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.
    Segman RH; Goltser T; Heresco-Levy U; Finkel B; Shalem R; Schlafman M; Yakir A; Greenberg D; Strous R; Lerner A; Shelevoy A; Lerer B
    Pharmacogenomics J; 2003; 3(5):277-83. PubMed ID: 14583797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder.
    Rajkumar RP
    Case Rep Psychiatry; 2014; 2014():215732. PubMed ID: 25478273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D3 receptor variant and tardive dyskinesia.
    Rietschel M; Krauss H; Müller DJ; Schulze TG; Knapp M; Marwinski K; Maroldt AO; Paus S; Grünhage F; Propping P; Maier W; Held T; Nöthen MM
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):31-5. PubMed ID: 10738862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.